When will capivasertib be available to breast cancer patients in Europe and the UK? Approval status, timelines, and all your options for accessing the medicine quickly.
Blog
-
January 15, 2024
-
January 15, 2024
Everything you need to know about nitrogacestat's approval in Europe and the UK. Including all your options to access the medicine earlier.
-
January 08, 2024
What's after Enhertu? Some of the alternatives your doctor may consider if Enhertu starts working.
-
December 12, 2023
How does Herceptin compare to Enhertu? Find out the similarities and differences between these two treatments for HER2-positive cancer.
-
December 12, 2023
What is the age limit for ruxolitinib? Find out all about the potential use of Opzelura on children.
-
December 06, 2023
When is margetuximab's EMA and MHRA approval expected? And what are your options in the meantime?
-
December 06, 2023
Is reportrectinib getting EMA approval soon, and how can you access it in the meantime?
-
December 06, 2023
How effective is fruquintinib for lung cancer? The latest clinical trial results, and what they could mean for your treatment.
-
December 04, 2023
What is the fastest migraine relief medicine that you can get in Europe and the UK in 2023?
-
November 21, 2023
When can colorectal cancer patients in Europe and the UK expect to have access to Fruzaqla?
-
November 20, 2023
When will Ojjaara be available to myelofibrosis patients in Europe and the UK? And what you can do in the meantime.
-
November 13, 2023
What patients in Europe and the UK need to know about vamorolone's availability timeline.
-
November 13, 2023
When will Zavegepant be available in the UK (and what to do in the meantime)
-
November 06, 2023
Where is Enhertu approved for the treatment of advanced NSCLC, and how can you access it?
-
October 30, 2023
How to safely access Ozempic in Australia until the medicine shortage is resolved.
-
October 30, 2023
How to safely access Ozempic in the UK until the medicine shortage is resolved.
-
October 30, 2023
How effective is Enhertu for colorectal cancer? Find out the latest trial results and what they can mean for your treatment.
-
October 17, 2023
Inclisiran could play a role in preventing cardiovascular events. Find out all about its availability in the UK, and what it can mean for you.
-
October 17, 2023
Pirtobrutinib is not yet approved and available in the EU and UK. But doesn't mean you can't access it immediately. Read on for all your options.
-
October 16, 2023
Belzutifan is currently approved as an orphan medicine in the UK. Find out when it will be widely available on the market, and what that means for you.
-
October 10, 2023
Everything you should know about Enhertu in the UK. What is it approved for, and how can you access it?
-
October 03, 2023
How effective is Enhertu for ovarian cancer, and can your doctor prescribe it before it's approved for this indication? All the answers - here.
-
October 03, 2023
What happens after Adakveo's revocation in the EU? Understand the reasons for the EMA's decision, and the Adakveo alternatives you have.
-
September 27, 2023
Find out the key similarities and differences between Adakveo and Oxbryta, including how to access both medicines.
-
September 25, 2023
When will dostarlimab be available in Belgium? Find out all the ways to access it in the meantime.
-
September 25, 2023
When will dostarlimab be available in the UK? Learn everything worth knowing about accessing the medicine.
-
September 25, 2023
Why teclistamab isn't available in Germany (yet) and how to access it in the meantime.
-
September 13, 2023
What types of cancer can dostarlimab treat? See all the latest approvals and research about this novel cancer treatment.
-
September 04, 2023
A simple overview of Jemperli and Keytruda as treatment options for endometrial cancer. Find out how they work, how efficient they are, and how much they cost.
-
August 29, 2023
Is it possible to combine Dupixent with Opzelura in your eczema treatment? All your questioned answered.